“Prevalence of glaucoma in the U.S. in 2022” study found higher prevalence of the eye disease than previously estimated
On Oct. 18, 2024, a study published in JAMA Ophthalmology, found that approximately 4.22 million people in the…
PET Scan based on lizard saliva detected rare tumor
On Oct. 18, 2024, a research team led by Radboud university medical center reported that a new PET…
Biotechnology | Diagnostics | Disease | Genomics | Life Science News | Therapeutics | Women's Health
Human skin map gives ‘recipe’ to build skin and could help prevent scarring
On Oct. 16, 2024, researchers from the Wellcome Sanger Institute, Newcastle University and their collaborators announced they had…
Biotechnology | Diagnostics | Disease | Life Science News | Medicine | Non-Profit Research | Pharmaceutical | Therapeutics
Sanofi commits $18 million to Howard University College of Medicine, Meharry Medical College, and Morehouse School of Medicine to increase diversity in clinical studies
On Oct. 16, 2024, Sanofi announced it will contribute $18 million to three Historically Black Medical Schools to…
Lundbeck to acquire Longboard Pharmaceuticals for $2.6 billion
On Oct. 14, 2024, Lundbeck and Longboard Pharmaceuticals announced an agreement for Lundbeck to acquire Longboard for payment…
U.S. FDA Approved Pfizer’s HYMPAVZI™ (marstacimab-hncq) for Treatment of Adults and Adolescents with Hemophilia A or B
On Oct. 11, 2024, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved HYMPAVZI™ (marstacimab-hncq)…
Biotechnology | Disease | FDA | Life Science News | Oncology | Therapeutics
FDA Approves Genentech’s Itovebi, a Targeted Treatment for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer With a PIK3CA Mutation
On Oct. 10, 2024, Genentech announced today that the U.S. Food and Drug Administration (FDA) approved ItovebiTM (inavolisib),…
Scientists develop a new method to study gene function in cells and tissue
On Oct. 7, 2024, Columbia University researchers announced they had developed a new optical pooled screening approach called…
FDA Approved Cologuard Plus Test, Setting New Benchmark in Colorectal Cancer Screening
On Oct. 4, 2024, Exact Sciences announced the U.S. Food and Drug Administration (FDA) had approved the Cologuard…
Combination Chemo Helps People with Leiomyosarcoma Live Longer
On Oct. 2, 2024, results from a French clinical trial have identified what experts say should now be…
Lilly announced $4.5 billion investment in the Lilly Medicine Foundry – to drive innovation in drug production and medicines for clinical trials
On Oct. 2, 2024, Eli Lilly and Company announced a $4.5 billion investment to create the Lilly Medicine…
Amneal Launched CREXONT® (Carbidopa and Levodopa) Extended-Release Capsules for Treatment of Parkinson’s Disease
On Sept. 30, 2024, Amneal Pharmaceuticals announced that it had launched CREXONT ® (carbidopa and levodopa) extended-release capsules…
Biotechnology | Diagnostics | Disease | Life Science News | Neurology | Non-Profit Research | Therapeutics
New mutation linked to early-onset Parkinsonism
On Sept. 26. 2024, a team of scientists led by Prof. Patrik Verstreken at the VIB-KU Leuven Center…
Stem cells reverse woman’s diabetes — a world first
On Sept. 26, 2024, a team of scientists in Peking University in Beijing, China announced that a 25-year-old…
Biology | Biotechnology | Diagnostics | Disease | Life Science News | Medicine | Neurology | Non-Profit Research | Therapeutics
landmark UT Health San Antonio study found genetic risk-factor overlap between Alzheimer’s disease, and dementias
On Sept. 17, 2024, in landmark research, scientists at The University of Texas Health Science Center at San…
Researchers discover new blood group system – MAL
On Sept. 16, 2024, researchers from NHS Blood and Transplant (Bristol), NHSBT’s International Blood Group Reference Laboratory (IBGRL)…
Cleveland Clinic Study Identified Key Factors That Can Impact Long-Term Weight Loss in Patients with Obesity Prescribed GLP-1 RA Medications
On Sep. 13, 2024, a Cleveland Clinic study was announced that identified key factors that can impact the…
Study Revealed How COVID-19 Infection Can Cause or Worsen Diabetes
On Sept. 13, 2024, researchers from Weill Cornell Medicine have used a cutting-edge model system to uncover the…
Agriculture | Biotechnology | Diagnostics | Disease | Influenza | Life Science News | Non-Profit Research | Vaccine | Veterinary
Avian flu found in wastewater of 10 Texas cities through virome sequencing
On Sep. 11, 2024, researchers at UTHealth Houston and Baylor College of Medicine reported that Avian influenza A(H5N1)…
Biology | Biotechnology | Diagnostics | Disease | Genomics | Life Science News | Non-Profit Research | Therapeutics
Human ‘Molecular Map’ Contributes to the Understanding of Disease Mechanisms
On Sep. 10, 2024, researchers at Weill Cornell Medicine in Qatar announced they had created a free-to-access online…
Gene therapy effective in hereditary blindness
On Sep. 10, 2024, researchers at the Karolinska Institute in Sweden announced a study that shows that gene…
Biotechnology | Disease | Genomics | Life Science News | Neurology | Non-Profit Research | Therapeutics
University of Copenhagen researchers discovered longevity gene
On Sep. 4, 2024, researchers at the University of Copenhagen announced the discovery of a gene that has…
RSV vaccine in older people reduced risk of hospitalization
On Sep. 4, 2024, researcher led by the Centers for Disease Control and Prevention (CDC) and Vanderbilt University…
WHO Data show marked increase in annual cholera deaths
On Sep. 4, 2024, the World Health Organization (WHO) published global cholera statistics for 2023, that showed an…
Biotechnology | Diagnostics | Disease | Life Science News | Oncology | Radiology | Therapeutics | Women's Health
False-positive mammogram results discourage some women from future screenings
On Sept. 3, 2024, a major study led by the UC Davis Comprehensive Cancer Center (UC DAVIS) has…
Biotechnology | Diagnostics | Disease | Life Science News | Neurology | Non-Profit Research | Therapeutics
Study Showed Over 10% of Medicare Beneficiaries Have Diagnoses Indicating Dementia
On Sept. 3, 2024, researchers at NORC at the University of Chicago and George Washington University’s Milken Institute…
Biotechnology | Diagnostics | Disease | Life Science News | NIH | Oncology | Radiology | Therapeutics | Women's Health
NCI’s Cancer Trends Progress Report announced 2023 Incidence and Mortality Data
On Sep. 3, 2024, the National Cancer Institute (NCI) announced that the latest Cancer Trends Progress Report included…
Biotechnology | Diagnostics | Disease | Life Science News | Neurology | Non-Profit Research | Therapeutics
CIRM Awarded $67.5 Million to Address Neuropsychiatric Diseases
On Aug. 30, 2024, the California Institute for Regenerative Medicine (CIRM) approved $67.5 million to support five projects…
Biotechnology | Disease | Life Science News | NIH | Non-Profit Research | Pharmaceutical | Therapeutics | Vaccine
Emergent BioSolutions’ ACAM2000® Received U.S. FDA Approval for Mpox Indication
On Aug. 29, 2024, Emergent BioSolutions announced that the U.S. Food and Drug Administration (FDA) had approved the supplemental Biologics…
Diagnostics | Disease | Genomics | Infectious Disease | Life Science News | Non-Profit Research | Oncology
Researchers mapped 50,000 of DNA’s mysterious ‘knots’ in the human genome
On Aug. 29, 2024, researchers at the Garvan Institute of Medical Research announced they had mapped 50,000 of…